NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1730140559 MD
Verify on CMS → Simi Masand Rai, MD
Medical Oncology Physician in Allentown, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 4,028 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
994
Medicare Part D claims · 224 beneficiaries · Medical Oncology Physician avg: 732
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$721.3
5 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Simi Masand Rai, MD filed 994 Medicare Part D claims in 2024 as a Medical Oncology Physician in Allentown, Pennsylvania, prescribing 90% generic.
- 994
- Part D claims, 2024
- 90%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥74th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Simi Masand Rai, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1730140559), first enumerated 03/31/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 994 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$721.3 in reported industry payments (5 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Pennsylvania statewide board action statistics are published annually — these figures describe aggregate state activity, not Simi Masand Rai, MD's individual license status. Verify directly with the state medical board.
Source: PA-BOM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1730140559 · Medical Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1730140559
- ENUM-LEGACY 2006
- TAX-NARROW 4,028
- RX-LIGHT 994
- BOOK-THIN 180 in Pennsylvania
- PHOTO-ENUM Murtaza Bhuriwala, MD · 2006
Simi Masand Rai, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
994 ≥ 74th percentile 74% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Simi Masand Rai, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Simi Masand Rai, MD?
Quality data not reportedPrimary specialty
Medical Oncology Physician
Medicare Part D claims
994 36% vs specialty avg
Specialty distribution in Pennsylvania
How Medical Oncology Physician compares to other specialties among Pennsylvania providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Medical Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1730140559 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 03/31/2006 |
Hospital and facility affiliations
Facilities where Simi Masand Rai, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Lehigh Valley Physician Group
Allentown, PA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Simi Masand Rai, MD. Source: openpaymentsdata.cms.gov.
Total received
$721
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Education
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Simi Masand Rai, MD. To verify Simi Masand Rai, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Simi Masand Rai, MD - brand share 10.0%
Medical Oncology Physician average
10% brand-name claims vs 90% generic, on 994 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
994
Total Claims
$964K
Total Drug Cost
224
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,941.133
- Total Day Supply
- 52,177
- Brand vs Generic
- 10% brand / 90% generic
- Brand Drug Cost
- $837K
- Generic Drug Cost
- $127K
- Opioid Claims
- 77 (7.7% rate)
Patient Demographics
- Average Patient Age
- 72.8 years
- Avg HCC Risk Score
- 1.47
- Gender Split
- 91% female / 9% male
- Age Distribution
- <65: 18, 65-74: 116, 75-84: 76, 85+: 14
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Simi Masand Rai, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Anastrozole
Anastrozole
335 claims
- Letrozole 90
Letrozole
90 claims
- Dexamethasone 82
Dexamethasone
82 claims
- Prochlorperazine M… 62
Prochlorperazine Maleate
62 claims
- Eliquis 41
Eliquis
41 claims
- Oxycodone Hcl 40
Oxycodone Hcl
40 claims
- Tamoxifen Citrate 39
Tamoxifen Citrate
39 claims
- Pantoprazole Sodium 21
Pantoprazole Sodium
21 claims
| Drug | Claims |
|---|---|
| Anastrozole | 335 |
| Letrozole | 90 |
| Dexamethasone | 82 |
| Prochlorperazine Maleate | 62 |
| Eliquis Apixaban | 41 |
| Oxycodone Hcl | 40 |
| Tamoxifen Citrate | 39 |
| Pantoprazole Sodium | 21 |
| Ondansetron Hcl | 17 |
| Exemestane | 16 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Simi Masand Rai, MD fits within the Medical Oncology Physician landscape nationally.
4,028
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
732
Avg Claims per Provider
Simi Masand Rai, MD's 994 claims are above the specialty average of 732.
Nationwide Medical Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Masand Rai, both outside Pennsylvania so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Medical Oncology Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Masand Rai.
One of 180 Medical Oncology Physician providers enrolled in Pennsylvania, 5 are shown here.
Dr. Maysa Abu-Khalaf
MD
Philadelphia, PA
Dr. Abdul Adjei
MD
Wilkes Barre, PA
Dr. Mohamed Ahmed
M.D
Pottstown, PA
Dr. Sramila Aithal
MD
Bensalem, PA
Dr. Heidar Albandar
MD
Fountain Hill, PA
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Simi Masand Rai, MD's specialty? ▼
Simi Masand Rai, MD specializes in Medical Oncology Physician and practices in Allentown, Pennsylvania. Credentials: MD.
How much does Simi Masand Rai, MD prescribe under Medicare Part D? ▼
In 2024, Simi Masand Rai, MD wrote 994 Medicare Part D claims totaling $964K in drug costs for 224 beneficiaries.
Where is Simi Masand Rai, MD located? ▼
Simi Masand Rai, MD is located at 1240 S CEDAR CREST BLVD STE 401, Allentown, PA, 18103. Phone: (610) 402-7880.
What is Simi Masand Rai, MD's NPI number? ▼
Simi Masand Rai, MD's National Provider Identifier (NPI) is 1730140559, issued on 03/31/2006.
Does Simi Masand Rai, MD prescribe more brand-name or generic drugs? ▼
Simi Masand Rai, MD's prescribing is 10% brand-name and 90% generic drugs by claim count, with $837K in brand drug costs.
Does Simi Masand Rai, MD prescribe opioids? ▼
Yes, Simi Masand Rai, MD had 77 opioid claims in 2024 with an opioid prescribing rate of 7.7%.
How many Medical Oncology Physician providers are there in the US? ▼
There are 4,028 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 732 Medicare Part D claims per year.
What drugs does Simi Masand Rai, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Simi Masand Rai, MD's most frequently prescribed drugs include Anastrozole, Letrozole, Dexamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Simi Masand Rai, MD accept Medicare? ▼
Simi Masand Rai, MD appears in CMS Medicare data with 994 Part D claims and 224 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Simi Masand Rai, MD's credentials? ▼
Simi Masand Rai, MD's NPI is 1730140559 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.